Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
541 to 560 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| ZICAI005133 | The Genome Analysis Core | 1 | 2025 |
| ZICDC000086 | Genomic and Computational Biology Support for NIDCD Intramural Research | 1 | 2025 |
| ZIDAI009004 | Laboratory Support Services | 1 | 2025 |
| ZIDES102465 | Program in Clinical Research, Clinical Support Services and Clinical Training | 1 | 2025 |
| D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 4 | 2024 |
| R01DK121072 | Optimization of the engineered 3D hepatic microenvironment enhances pluripotent stem cell derived hepatocyte | 4 | 2024 |
| RC2DK122532 | Identifying Immune and Epithelial Network Signatures in Very Early Onset Inflammatory Bowel Disease | 4 | 2024 |
| T32GM080202 | Medical Scientist Training Program | 4 | 2024 |
| P30EY031631 | Center Core Grant for Vision Research | 3 | 2024 |
| R01AI142841 | Maternal obesity and neonatal innate immunity | 3 | 2024 |
| R01CA116021 | New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors | 3 | 2024 |
| P01AG049665 | Disordered Proteostasis as a Driver of Disease in the Aging Lung | 2 | 2024 |
| R01AI145910 | Dysregulation of maternal immunity during pregnancy by pregravid obesity | 2 | 2024 |
| R01AI149672 | Defining Mechanisms of Viral Persistence in Situ at the Single-Cell Level | 2 | 2024 |
| R01CA251275 | Structural analysis and therapeutic nanobody development of KSHV G-protein coupled receptor | 2 | 2024 |
| R01DE023926 | KSHV Epigenetic Regulation | 2 | 2024 |
| R01HL136137 | T cell Epitope Discovery in Sarcoidosis | 2 | 2024 |
| T32DK007074 | Digestive Health and Diseases (DHD) Training Grant | 2 | 2024 |
| T32HL125241 | Pediatric Cardiovascular and Pulmonary Research Training Program | 2 | 2024 |
| U24AI120134 | Development of multi-modal single-cell technology to dissect epitope specificity to HIV | 2 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=28